The aim of the present study was to assess the innervation pattern in benign haemangiomata, malignant colo-rectal carci-nomata and experimental malignant tumours transplanted into severe combined immunodeficient (SCID) mice using the general nerve fibre marker protein gene product (PGP) 9.5. An indirect immunohistological technique (using streptavidin-biotin complex formation) was used on paraffin wax sections of tumour tissues fixed in neutral buffered formalin. In 5/7 haemangiomata nerve fibres were detected in the vicinity of some tumorous blood vessels, though the majority of such vessels were without immunoreactive nerve fibres. In some cases the reaction product for PGP 9.5 appeared to be distributed in a diffuse perivascular manner. In the colo-rectal carcinomata, no intra-tumorous blood vessels received a nerve supply, though nerves were observed in the stroma supporting the tumour tissues. In the experimental tumours derived from either human colo-rectal carcinomata or breast carcinomata cell lines, no nerve fibres were detected within the tumours themselves. The conclusions reached were that tumour blood vessels are not innervated. Angiogenesis, which is a prerequisite for tumour growth, must, therefore, be regulated by a means other than neural.

Keywords:
Benign, Malignant, Experimental tumours, Innervation, PGP 9.5, Immunohistology
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.